» Articles » PMID: 39100705

Causal Association of Arterial Stiffness With the Risk of Chronic Kidney Disease

Overview
Journal JACC Asia
Date 2024 Aug 5
PMID 39100705
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Previous studies on the direction of the association between arterial stiffness (AS) and chronic kidney disease (CKD) were inconsistent, leaving a knowledge gap in understanding the temporal sequence of the association.

Objectives: This study sought to assess the temporal and longitudinal relationship between AS and CKD.

Methods: The temporal relationship between AS measured by brachial ankle pulse wave velocity and CKD measured by estimated glomerular filtration rate (eGFR) was analyzed among 7,753 participants with repeated examinations in the Kailuan study using cross-lagged panel analysis. The longitudinal associations of AS status and vascular aging (VA) phenotype with incident CKD were analyzed among 10,535 participants.

Results: The adjusted cross-lagged path coefficient ( = -0.03; 95% CI: -0.06 to -0.01;  < 0.0001) from baseline brachial ankle pulse wave velocity to follow-up eGFR was significantly greater than the path coefficient ( = -0.01; 95% CI: -0.02 to 0.01;  = 0.6202) from baseline eGFR to follow-up brachial ankle pulse wave velocity ( < 0.0001 for the difference). During a median follow-up of 8.48 years, 953 cases of incident CKD (9.05%) occurred. After adjustment for confounders, borderline (HR: 1.17; 95% CI: 1.08-1.38) and elevated AS (HR: 1.39; 95% CI: 1.12-1.72) was associated a higher risk of CKD, compared with normal AS. Consistently, supernormal VA (HR: 0.76; 95% CI: 0.66-0.86) was associated with a decreased and early VA (HR: 1.36; 95% CI: 1.29-1.43) was associated with an increased risk of CKD, compared with normal VA.

Conclusions: AS appeared to precede the decrease in eGFR. Additionally, increased AS and early VA were associated with an increased risk of incident CKD.

References
1.
Kalil R, Wang J, de Boer I, Mathew R, Ix J, Asif A . Effect of extended-release niacin on cardiovascular events and kidney function in chronic kidney disease: a post hoc analysis of the AIM-HIGH trial. Kidney Int. 2015; 87(6):1250-7. PMC: 4449803. DOI: 10.1038/ki.2014.383. View

2.
Azukaitis K, Kirchner M, Doyon A, Litwin M, Bayazit A, Duzova A . Arterial Stiffness and Chronic Kidney Disease Progression in Children. Clin J Am Soc Nephrol. 2022; 17(10):1467-1476. PMC: 9528270. DOI: 10.2215/CJN.02200222. View

3.
. Chapter 1: Definition and classification of CKD. Kidney Int Suppl (2011). 2014; 3(1):19-62. PMC: 4089693. DOI: 10.1038/kisup.2012.64. View

4.
Ford M, Tomlinson L, Chapman T, Rajkumar C, Holt S . Aortic stiffness is independently associated with rate of renal function decline in chronic kidney disease stages 3 and 4. Hypertension. 2010; 55(5):1110-5. DOI: 10.1161/HYPERTENSIONAHA.109.143024. View

5.
Climie R, Picone D, Blackwood S, Keel S, Qasem A, Rattigan S . Pulsatile interaction between the macro-vasculature and micro-vasculature: proof-of-concept among patients with type 2 diabetes. Eur J Appl Physiol. 2018; 118(11):2455-2463. DOI: 10.1007/s00421-018-3972-2. View